Kidney TransplantationTransplantsGraft RejectionGraft SurvivalImmunosuppressive AgentsHeart TransplantationTransplantation, HomologousTissue DonorsTissue and Organ ProcurementTransplantationLung TransplantationBone Marrow TransplantationCyclosporineTacrolimusLiving DonorsWaiting ListsTreatment OutcomePostoperative ComplicationsImmunosuppressionTime FactorsHematopoietic Stem Cell TransplantationRetrospective StudiesCytomegalovirus InfectionsFetal Tissue TransplantationMycophenolic AcidCadaverHistocompatibility TestingTransplantation ImmunologyImmunocompromised HostKidney Failure, ChronicLiver FailureGraft vs Host DiseaseHeart-Lung TransplantationTransplantation, AutologousBrain Tissue TransplantationRisk FactorsOrgan TransplantationBronchiolitis ObliteransFollow-Up StudiesTransplantation, HeterotopicKidneyHistocompatibilityTransplantation ToleranceCytomegalovirusOpportunistic InfectionsTransplantation ConditioningBK VirusRecurrenceSurvival RateSurvival AnalysisBiopsyHLA AntigensGanciclovirAntilymphocyte SerumIsoantibodiesMultiple Organ FailureLymphoproliferative DisordersPolyomavirus InfectionsProspective StudiesLiver DiseasesEnd Stage Liver DiseaseBrain DeathTransplantation, IsogeneicKidney DiseasesHematologic NeoplasmsCreatinineIslets of Langerhans TransplantationIncidenceMycosesOrgan SizeAcute DiseasePostoperative PeriodTissue and Organ HarvestingFatal OutcomePrimary Graft DysfunctionAntiviral AgentsWhole-Body IrradiationOrgan SpecificityStem Cell TransplantationPrognosisSirolimusDirected Tissue DonationCohort StudiesOrgan of CortiCalcineurinPatient SelectionTransplantation ChimeraInfectionDrug Therapy, CombinationRenal DialysisRegistriesTissue TransplantationLeukemiaCord Blood Stem Cell TransplantationKaplan-Meier EstimateRisk AssessmentFacial TransplantationCyclosporinsCorneal TransplantationProportional Hazards Models